| EMA number | EMEA/H/C/004258 |
| ATC code | L04 |
| Authorisation | 23 March 2018 |
| Withdrawn | 13 December 2024 |
| Revision | 12 |
Alofisel is indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy. Alofisel should be used after conditioning of fistula.